Comparison of platelet quality and function across apheresis collection platforms

Kimberly A. Thomas, Amudan J. Srinivasan, Colby McIntosh, Katelin Rahn, Scott Kelly, Lilian McGough, Skye Clayton, Samantha Perez, Alexandra Smith, Lisa Vavro, Javonn Musgrove, Ronnie Hill, Kennedy S. Mdaki, James A. Bynum, M. Adam Meledeo, Andrew P. Cap, Philip C. Spinella, Kristin M. Reddoch-Cardenas, Susan M. Shea*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

4 Scopus citations


Background: Platelet concentrates (PLT) can be manufactured using a combination of apheresis collection devices and suspension media (plasma or platelet additive solution (PAS)). It is unclear how platelet quality and hemostatic function differ across the current in-use manufacturing methods in the United States. The objective of this study was therefore to compare baseline function of PLT collected using different apheresis collection platforms and storage media. Study Design and Methods: PLT were collected at two sites with identical protocols (N = 5 per site, N = 10 total per group) on the MCS® + 9000 (Haemonetics; “MCS”), the Trima Accel® 7 (Terumo; “Trima”), and the Amicus Cell Separator (Fresenius Kabi, “Amicus”). MCS PLT were collected into plasma while Trima and Amicus PLT were collected into plasma or PAS (Trima into Isoplate and Amicus into InterSol; yielding groups “TP”, “TI” and “AP”, “AI”, respectively). PLT units were sampled 1 h after collection and assayed to compare cellular counts, biochemistry, and hemostatic function. Results: Differences in biochemistry were most evident between plasma and PAS groups, as anticipated. MCS and TP had the highest clot strength as assessed by viscoelastometry. AI had the lowest thrombin generation capacity. Both TP and TI had the highest responses on platelet aggregometry. AI had the greatest number of microparticles. Discussion: Platelet quality and function differ among collection platforms at baseline. MCS and Trima platelets overall appear to trend toward higher hemostatic function. Future investigations will assess how these differences change throughout storage, and if these in vitro measures are clinically relevant.

Original languageEnglish
Pages (from-to)S146-S158
Issue numberS3
StatePublished - May 2023
Externally publishedYes


Dive into the research topics of 'Comparison of platelet quality and function across apheresis collection platforms'. Together they form a unique fingerprint.

Cite this